Compare XRTX & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRTX | INTZ |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 16.9M |
| IPO Year | 2018 | 2020 |
| Metric | XRTX | INTZ |
|---|---|---|
| Price | $2.21 | $0.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 33.4K | ★ 125.8K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,015,000.00 |
| Revenue This Year | N/A | $25.34 |
| Revenue Next Year | N/A | $14.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.56 |
| 52 Week Low | $0.35 | $0.69 |
| 52 Week High | $3.60 | $2.64 |
| Indicator | XRTX | INTZ |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 44.49 |
| Support Level | $2.01 | $0.73 |
| Resistance Level | $3.03 | $1.20 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 20.77 | 26.98 |
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.